Lakshmi Changolkar

3.0k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

Lakshmi Changolkar is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Lakshmi Changolkar has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 17 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Lakshmi Changolkar's work include Alzheimer's disease research and treatments (20 papers), Prion Diseases and Protein Misfolding (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Lakshmi Changolkar is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Prion Diseases and Protein Misfolding (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Lakshmi Changolkar collaborates with scholars based in United States, China and Switzerland. Lakshmi Changolkar's co-authors include Virginia M.‐Y. Lee, John Q. Trojanowski, Bin Zhang, Sneha Narasimhan, Jennifer D. McBride, John R. Pehrson, Zhuohao He, Jing Guo, Anna Stieber and Ronald J. Gathagan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lakshmi Changolkar

29 papers receiving 2.0k citations

Hit Papers

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pa... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lakshmi Changolkar United States 20 1.3k 932 574 352 294 29 2.0k
Caitlin Commins United States 14 1.1k 0.9× 1.2k 1.3× 393 0.7× 501 1.4× 204 0.7× 21 2.1k
Sneha Narasimhan United States 18 1.3k 1.0× 638 0.7× 729 1.3× 456 1.3× 246 0.8× 23 2.0k
Dag Sehlin Sweden 33 1.6k 1.2× 1.3k 1.4× 619 1.1× 418 1.2× 301 1.0× 85 3.0k
Susanna Schraen‐Maschke France 25 1.2k 0.9× 812 0.9× 387 0.7× 481 1.4× 347 1.2× 66 2.0k
Yukio Matsuba Japan 14 1.6k 1.2× 841 0.9× 556 1.0× 493 1.4× 170 0.6× 25 2.3k
Allyson D. Roe United States 18 1.3k 1.0× 1.1k 1.2× 517 0.9× 435 1.2× 213 0.7× 22 2.2k
Thomas M. Wengenack United States 28 1.4k 1.0× 1.0k 1.1× 304 0.5× 406 1.2× 177 0.6× 40 2.3k
Simon Dujardin United States 19 1.7k 1.3× 1.5k 1.7× 625 1.1× 710 2.0× 352 1.2× 30 3.0k
Hwan‐Ching Tai Taiwan 19 1.1k 0.8× 1.1k 1.1× 365 0.6× 573 1.6× 162 0.6× 41 2.3k
Ayodeji A. Asuni United States 21 1.3k 1.0× 884 0.9× 519 0.9× 566 1.6× 246 0.8× 57 2.0k

Countries citing papers authored by Lakshmi Changolkar

Since Specialization
Citations

This map shows the geographic impact of Lakshmi Changolkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmi Changolkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmi Changolkar more than expected).

Fields of papers citing papers by Lakshmi Changolkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakshmi Changolkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmi Changolkar. The network helps show where Lakshmi Changolkar may publish in the future.

Co-authorship network of co-authors of Lakshmi Changolkar

This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmi Changolkar. A scholar is included among the top collaborators of Lakshmi Changolkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmi Changolkar. Lakshmi Changolkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brynildsen, Julia K., Cheryl E. G. Leyns, Lakshmi Changolkar, et al.. (2024). LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression. Translational Neurodegeneration. 13(1). 13–13. 7 indexed citations
2.
Xu, Hong, Qi Qiu, Peng Hu, et al.. (2024). MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons. Acta Neuropathologica. 147(1). 55–55. 3 indexed citations
3.
Farber, Emmanuel, Lakshmi Changolkar, Bin Zhang, et al.. (2024). Targeting Endogenous Tau in Seeded Tauopathy Models Inhibits Tau Spread. Journal of Neuroscience. 44(48). e0877242024–e0877242024. 1 indexed citations
4.
Duan, Pu, Aurelio J. Dregni, Hong Xu, et al.. (2024). Alzheimer’s disease seeded tau forms paired helical filaments yet lacks seeding potential. Journal of Biological Chemistry. 300(9). 107730–107730. 8 indexed citations
5.
McBride, Jennifer D., et al.. (2022). Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization. Acta Neuropathologica Communications. 10(1). 30–30. 18 indexed citations
6.
Xu, Hong, Garrett S. Gibbons, Lakshmi Changolkar, et al.. (2021). In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics. Acta Neuropathologica. 141(2). 193–215. 40 indexed citations
7.
Henderson, Michael X., Lakshmi Changolkar, John Q. Trojanowski, & Virginia M.‐Y. Lee. (2021). LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons. Journal of Parkinson s Disease. 11(3). 1187–1196. 6 indexed citations
8.
Narasimhan, Sneha, Zhuohao He, Lakshmi Changolkar, et al.. (2020). Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo. Journal of Neuropathology & Experimental Neurology. 79(9). 941–949. 10 indexed citations
9.
Gibbons, Garrett S., Soojung Kim, Qihui Wu, et al.. (2020). Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease. Molecular Neurodegeneration. 15(1). 64–64. 30 indexed citations
10.
He, Zhuohao, Jennifer D. McBride, Hong Xu, et al.. (2020). Transmission of tauopathy strains is independent of their isoform composition. Nature Communications. 11(1). 7–7. 135 indexed citations
11.
Prokop, Stefan, Kelly R. Miller, Sneha Narasimhan, et al.. (2019). Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer’s disease patient brain samples. Acta Neuropathologica. 138(4). 613–630. 73 indexed citations
12.
Gibbons, Garrett S., Soojung Kim, John Robinson, et al.. (2019). Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau). Acta Neuropathologica Communications. 7(1). 34–34. 29 indexed citations
13.
Gibbons, Garrett S., Rachel A. Banks, Bumjin Kim, et al.. (2018). Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Journal of Neuropathology & Experimental Neurology. 77(3). 216–228. 61 indexed citations
14.
Narasimhan, Sneha, Jing Guo, Lakshmi Changolkar, et al.. (2017). Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain. Journal of Neuroscience. 37(47). 11406–11423. 277 indexed citations
15.
Gibbons, Garrett S., Rachel A. Banks, Bumjin Kim, et al.. (2017). GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Journal of Neuroscience. 37(47). 11485–11494. 37 indexed citations
16.
He, Zhuohao, Jing Guo, Jennifer D. McBride, et al.. (2017). Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nature Medicine. 24(1). 29–38. 449 indexed citations breakdown →
17.
Pehrson, John R., Lakshmi Changolkar, Carl Costanzi, & N. Adrian Leu. (2014). Mice without MacroH2A Histone Variants. Molecular and Cellular Biology. 34(24). 4523–4533. 61 indexed citations
18.
Baudino, Lucie, Lakshmi Changolkar, John R. Pehrson, & Shozo Izui. (2010). The Sgp3 locus derived from the 129 strain is responsible for enhanced endogenous retroviral expression in macroH2A1-deficient mice. Journal of Autoimmunity. 35(4). 398–403. 6 indexed citations
19.
Changolkar, Lakshmi, et al.. (2008). macroH2A1-Dependent Silencing of Endogenous Murine Leukemia Viruses. Molecular and Cellular Biology. 28(6). 2059–2065. 33 indexed citations
20.
Changolkar, Lakshmi & John R. Pehrson. (2003). Histone MacroH2A Purification and Nucleosome Reconstitution. Methods in enzymology on CD-ROM/Methods in enzymology. 375. 228–238. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026